Human Phenotype Ontology 
Grandparent Node:
expand
Morphological central nervous system abnormality (HP:0002011)help
Parent Node:
expand
Atrophy/Degeneration affecting the central nervous system (HP:0007367)help
..Starting node
..expand
Increased cerebral lipofuscin (HP:0011813)help
Term ID: 11813
Name: Increased cerebral lipofuscin
Synonym:
Definition: Lipofuscin (age pigment) is a brown-yellow, electron-dense, autofluorescent material that accumulates progressively over time in lysosomes of postmitotic cells, such as neurons and cardiac myocytes. This term pertains if there is an increase in the accumulation of lipofuscin (also known as autofluorescent lipoprotein) more than expected for the age of the patient.
Comments:
Reference: HP:0011813
Genes and Diseases:
 
       Child Nodes:
........expandIncreased neuronal autofluorescent lipopigment (HP:0002074) help
........expandIncreased extraneuronal autofluorescent lipopigment (HP:0003463) help

 Sister Nodes: 
..expandAtrophy/Degeneration affecting the brainstem (HP:0007366) help
..expandAtrophy/Degeneration involving the corticospinal tracts (HP:0007372) help
..expandAtrophy/Degeneration involving the spinal cord (HP:0007344) help
..expandBrain atrophy (HP:0012444) help
..expandCentral nervous system degeneration (HP:0007009) help
..expandMotor neuron atrophy (HP:0007373) help
..expandNeurodegeneration (HP:0002180) help
..expandNeuronal loss in central nervous system (HP:0002529) help
..expandSenile plaques (HP:0100256) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011813HP:0011813Increased cerebral lipofuscin0CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3216
HP:0011813HP:0011813Increased cerebral lipofuscin0CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5141
HP:0011813HP:0011813Increased cerebral lipofuscin0CLN6 CL E G H549822077OMIM:204300Ceroid lipofuscinosis, neuronal, 4A, autosomal recessive143
HP:0011813HP:0011813Increased cerebral lipofuscin0CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6143
HP:0011813HP:0011813Increased cerebral lipofuscin0CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8111
HP:0011813HP:0011813Increased cerebral lipofuscin0CLN8 CL E G H20552079OMIM:610003Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant111
HP:0011813HP:0011813Increased cerebral lipofuscin0CTSD CL E G H15092529OMIM:610127Ceroid lipofuscinosis, neuronal, 10159
HP:0011813HP:0011813Increased cerebral lipofuscin0DNAJC5 CL E G H8033116235OMIM:162350Ceroid lipofuscinosis, neuronal, 4B, autosomal dominant155
HP:0011813HP:0011813Increased cerebral lipofuscin0PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1172
HP:0011813HP:0011813Increased cerebral lipofuscin0PSAP CL E G H56609498OMIM:610539Gaucher disease, atypical.81
HP:0011813HP:0011813Increased cerebral lipofuscin0TARS2 CL E G H8022230740OMIM:615918Combined oxidative phosphorylation deficiency 2128
HP:0011813HP:0011813Increased cerebral lipofuscin0TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2203
HP:0011813HP:0003463Increased extraneuronal autofluorescent lipopigment1CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3.216
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3.216
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5.141
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CLN6 CL E G H549822077OMIM:204300Ceroid lipofuscinosis, neuronal, 4A, autosomal recessive.143
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6.143
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8.111
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CLN8 CL E G H20552079OMIM:610003Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant.111
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1CTSD CL E G H15092529OMIM:610127Ceroid lipofuscinosis, neuronal, 10.159
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1DNAJC5 CL E G H8033116235OMIM:162350Ceroid lipofuscinosis, neuronal, 4B, autosomal dominant.155
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1.172
HP:0011813HP:0003463Increased extraneuronal autofluorescent lipopigment1TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2.203
HP:0011813HP:0002074Increased neuronal autofluorescent lipopigment1TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2.203


Genes (10) :CLN3 CLN5 CLN6 CLN8 CTSD DNAJC5 PPT1 PSAP TARS2 TPP1

Diseases (12) :OMIM:204200 OMIM:256731 OMIM:204300 OMIM:601780 OMIM:600143 OMIM:610003 OMIM:610127 OMIM:162350 OMIM:256730 OMIM:610539 OMIM:615918 OMIM:204500
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.